aTYR PHARMA INC: capex
| Value | {"amount": 10000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-03-31 |
| Status | current |
| Entity | aTYR PHARMA INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:49:28.461302+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7f83fa9a-99f6-46a0-9152-ebf346b7caab
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-19-019133 · Open the official SEC filing →Retrieved: 2026-08-19T12:49:28.461302+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001339970/capex/2019-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7f83fa9a-99f6-46a0-9152-ebf346b7caab
History
- no predecessors — first report